Correlation Between MediciNova and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MediciNova and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Fennec Pharmaceuticals, you can compare the effects of market volatilities on MediciNova and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Fennec Pharmaceuticals.
Diversification Opportunities for MediciNova and Fennec Pharmaceuticals
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MediciNova and Fennec is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of MediciNova i.e., MediciNova and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between MediciNova and Fennec Pharmaceuticals
Given the investment horizon of 90 days MediciNova is expected to generate 2.01 times more return on investment than Fennec Pharmaceuticals. However, MediciNova is 2.01 times more volatile than Fennec Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about 0.17 per unit of risk. If you would invest 163.00 in MediciNova on August 28, 2024 and sell it today you would earn a total of 42.00 from holding MediciNova or generate 25.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| MediciNova |
| Fennec Pharmaceuticals |
MediciNova and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Fennec Pharmaceuticals
The main advantage of trading using opposite MediciNova and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
| Fennec Pharmaceuticals vs. Eliem Therapeutics | Fennec Pharmaceuticals vs. HCW Biologics | Fennec Pharmaceuticals vs. Scpharmaceuticals | Fennec Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |